NASDAQ:KARD Kardigan (KARD) Stock Price, News & Analysis $16.64 -0.05 (-0.30%) As of 09/18/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsOwnershipSEC Filings About Kardigan Stock (NASDAQ:KARD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Kardigan alerts:Sign Up Key Stats Today's Range$15.86▼$17.0050-Day Range$16.64▼$23.5352-Week Range$15.86▼$27.00Volume6.57 million shsAverage Volume382,854 shsMarket Capitalization$1.56 billionP/E RatioN/ADividend YieldN/APrice Target$42.25Consensus RatingModerate Buy Company Overview Kardigan is a biopharmaceutical company focused on developing therapies for cardiovascular and related serious diseases. Its activities center on the discovery and clinical development of innovative medicines intended to address significant unmet medical needs. The company operates as a research- and development-stage business, with its principal activities involving drug discovery, preclinical research, clinical testing and potential commercialization of pharmaceutical products. Publicly available information about Kardigan’s specific product portfolio and development programs is limited. Detailed information about Kardigan’s corporate history, geographic operations and leadership was not available from reliable sources.AI Generated. May Contain Errors. Read More Kardigan Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks75th Percentile Overall ScoreKARD MarketRank™: Kardigan scored higher than 75% of companies evaluated by MarketBeat, and ranked 148th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingKardigan has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 4 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialKardigan has a consensus price target of $42.25, representing about 153.9% upside from its current price of $16.64.Amount of Analyst CoverageKardigan has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Kardigan's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Kardigan are expected to grow in the coming year, from ($3.41) to ($3.35) per share. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted2.36% of the float of Kardigan has been sold short.Short Interest Ratio / Days to CoverKardigan has a short interest ratio ("days to cover") of 9.11.Change versus previous monthShort interest in Kardigan has recently increased by 13.97%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldKardigan does not currently pay a dividend.Dividend GrowthKardigan does not have a long track record of dividend growth. News and Social Media2.5 / 5News SentimentN/A News SentimentKardigan has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.Search InterestOnly 2 people have searched for KARD on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership3.6 / 5Insider TradingAcquiring Shares Cluster Insider Buying2 insiders have purchased shares of Kardigan in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $40,000,000.00 in company stock, which represents 2.5710% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Kardigan insiders have bought more of their company's stock than they have sold. Specifically, they have bought $40,000,000.00 in company stock and sold $0.00 in company stock.Percentage Held by InstitutionsKardigan has minimal institutional ownership at this time.Read more about Kardigan's insider trading history. Receive KARD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kardigan and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KARD Stock News HeadlinesKardigan: Funded Precision Cardiology Offers More Than Pipeline DiversificationSeptember 13, 2026 | seekingalpha.comKardigan, Inc. (NASDAQ:KARD) Receives $42.25 Consensus PT from AnalystsSeptember 10, 2026 | americanbankingnews.comMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon adviser Jim Rickards publicly predicted a Trump victory before election night. Now Rickards is issuing a new forecast he calls a potential mid-term meltdown, one he believes could send shockwaves through financial markets.September 20 at 1:00 AM | Paradigm Press (Ad)Kardigan to Present at Two September Investor ConferencesSeptember 2, 2026 | businesswire.comKardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ RadarSeptember 2, 2026 | tipranks.comKardigan Inc (KARD) Stock Price, Quote, News & HistoryAugust 20, 2026 | benzinga.comWe've developed a first-of-its-kind medicine to battle cardiovascular disease: Kardigan CEOJune 26, 2026 | msn.comHow Kardigan spun deal leftovers into a $400M IPOJune 24, 2026 | finance.yahoo.comSee More Headlines KARD Stock Analysis - Frequently Asked Questions How have KARD shares performed this year? Kardigan's stock was trading at $22.00 on June 18, 2026. Since then, KARD shares have decreased by 24.4% and is now trading at $16.64. How were Kardigan's earnings last quarter? Kardigan, Inc. (NASDAQ:KARD) posted its quarterly earnings results on Tuesday, August, 11th. The company reported ($4.61) EPS for the quarter. When did Kardigan IPO? Kardigan (KARD) raised $375 million in an initial public offering (IPO) on Thursday, June 18th 2026. The company issued 25,000,000 shares at a price of $14.00-$16.00 per share. When did Kardigan's quiet period expire? Kardigan's quiet period expired on Tuesday, July 28th. Kardigan had issued 25,000,000 shares in its initial public offering on June 18th. The total size of the offering was $400,000,000 based on an initial share price of $16.00. During Kardigan's quiet period, underwriters and any insiders involved in the IPO were prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company. Who are Kardigan's major shareholders? Top institutional shareholders of Kardigan include Jupiter Topco LLC (0.80%), Montanova Capital LLC (0.43%), Bank of New York Mellon Corp (0.42%) and Braidwell LP (0.32%). Insiders that own company stock include Paul L Berns and Arch Venture Partners Xiii, Ll. View institutional ownership trends. How do I buy shares of Kardigan? Shares of KARD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/11/2026Today9/20/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:KARD CIK2123613 Webwww.kardigan.bio Phone415-573-3220FaxN/AEmployees241Year FoundedN/APrice Target and Rating Average Price Target for Kardigan$42.25 High Price Target$46.00 Low Price Target$37.00 Potential Upside/Downside+153.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares93,500,000Free FloatN/AMarket Cap$1.56 billion OptionableN/A BetaN/A 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:KARD) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredBefore Anthropic becomes impossible to ignore...Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...The Oxford Club | SponsoredWhy This Small AI Company Holds 150 PatentsJeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...Brownstone Research | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | SponsoredNo Wallstreet. No Advisor. No Problem.Savings accounts pay just 0.58 percent interest. Andy Howard, co-founder of Meridian Capital, says liquidity p...Awesomely | SponsoredGold majors have a big problemNewmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet prod...Golden Portfolio | SponsoredIran War WARNING: Something Just ChangedA powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kardigan, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kardigan With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
